Skip to main content

3 Reasons to Sell CPB and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

CPB Cover Image

What a brutal six months it’s been for Campbell's. The stock has dropped 25.7% and now trades at $20.57, rattling many shareholders. This might have investors contemplating their next move.

Is now the time to buy Campbell's, or should you be careful about including it in your portfolio? Get the full breakdown from our expert analysts, it’s free.

Why Do We Think Campbell's Will Underperform?

Even with the cheaper entry price, we don’t have much confidence in Campbell's. Here are three reasons why there are better opportunities than CPB, plus one stock we’d rather own.

1. Demand Slipping as Sales Volumes Decline

Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there’s a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive.

Campbell’s average quarterly sales volumes have shrunk by 1.6% over the last two years. This decrease isn’t ideal because the quantity demanded for consumer staples products is typically stable. Campbell's Year-On-Year Volume Growth

2. Revenue Projections Show Stormy Skies Ahead

Forecasted revenues by Wall Street analysts signal a company’s potential. Predictions may not always be accurate, but accelerating growth typically boosts valuation multiples and stock prices while slowing growth does the opposite.

Over the next 12 months, sell-side analysts expect Campbell’s revenue to drop by 2.1%, a decrease from This projection is underwhelming and suggests its products will see some demand headwinds.

3. EPS Trending Down

We track the long-term change in earnings per share (EPS) because it highlights whether a company’s growth is profitable.

Sadly for Campbell's, its EPS declined by 7.8% annually over the last three years while its revenue grew by 2.3%. This tells us the company became less profitable on a per-share basis as it expanded.

Campbell's Trailing 12-Month EPS (Non-GAAP)

Final Judgment

Campbell's doesn’t pass our quality test. Following the recent decline, the stock trades at 10.8× forward P/E (or $20.57 per share). While this valuation is reasonable, we don’t see a big opportunity at the moment. There are better investments elsewhere. We’d recommend looking at one of Charlie Munger’s all-time favorite businesses.

Stocks We Like More Than Campbell's

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don’t just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn’t over. Find out which 9 stocks made the cut this week — FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.11
+1.32 (0.57%)
AAPL  294.30
-2.71 (-0.91%)
AMD  519.85
-31.78 (-5.76%)
BAC  57.91
+0.54 (0.94%)
GOOG  346.08
-2.70 (-0.77%)
META  562.20
-1.65 (-0.29%)
MSFT  373.94
+6.60 (1.80%)
NVDA  200.04
-8.61 (-4.13%)
ORCL  165.16
-9.91 (-5.66%)
TSLA  381.61
-23.44 (-5.79%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.